YD Bio Ltd. -30YDESWPreferred / convertible
13F holders, Q1 2026 (March 31)9holders −3
0new positions
3sold out
$0.78avg. 13F price*
At the end of Q1 2026, 9 institutions reported holding YD Bio Ltd. -30 (YDESW) in their 13F filings, down 3 from Q4 2025. 0 opened new positions and 3 sold out. The largest holders were Cypress Capital Management LLC (WY) ($3.0M), Oasis Management Co Ltd. ($770K) and Cerity Partners LLC ($208K).
- Company
- YD Bio Ltd. -30
- CUSIP
- G9835J103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $15K |
All 13F filers, Q4 2025 → Q1 2026: 199,392 shares bought and 15,825 shares sold, net +183,567 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Cypress Capital Management LLC (WY) | — | Add +3.2% | 4,589,850 | $3.0M |
| Oasis Management Co Ltd. | — | No change | 100,000 | $770K |
| Cerity Partners LLC | — | No change | 320,089 | $208K |
| True North Advisors, LLC | — | Reduce -0.1% | 220,819 | $144K |
| Clear Street Group Inc. | — | Add +8.7% | 102,358 | $67K |
| Aristeia Capital, L.L.C. | — | Add +376.7% | 63,274 | $37K |
| Merit Financial Group, LLC | — | No change | 40,000 | $26K |
| Concurrent Investment Advisors, LLC | — | No change | 17,672 | $11K |
| Summit Securities Group LLC | — | No change | 1 | $1 |
"% of holder's portfolio" is YDESW's weight in each manager's 13F, not the share of YD Bio Ltd. -30 the manager owns.